Detalles de la búsqueda
1.
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
Blood
; 132(3): 264-276, 2018 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29720486
2.
Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimen.
Haematologica
; 105(4): 1013-1020, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31371414
3.
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology.
Blood
; 129(20): 2771-2781, 2017 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28331056
4.
High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 66(8): e27780, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31034759
5.
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Haematologica
; 103(1): 107-115, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29079599
6.
T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.
Genes Chromosomes Cancer
; 56(2): 159-167, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717083
7.
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
Br J Haematol
; 179(2): 272-283, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28771662
8.
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
Pediatr Blood Cancer
; 64(10)2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28371317
9.
Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.
Br J Haematol
; 172(6): 855-69, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26773444
10.
Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 62(9): 1656-60, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25833113
11.
TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia.
Haematologica
; 104(9): e402-e405, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31289210
12.
Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy.
Leuk Lymphoma
; 60(1): 78-84, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29718744
13.
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).
J Clin Oncol
; 36(3): 244-253, 2018 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29148893
14.
IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
J Clin Oncol
; 36(12): 1240-1249, 2018 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29498923
15.
Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia - first findings of the OPAL trial.
Leuk Lymphoma
; 58(10): 2363-2369, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28140726
Resultados
1 -
15
de 15
1
Próxima >
>>